Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | SLNO | XNCR | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Soleno Therapeutics Inc | Xencor Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.00 | 44.75 | 23.86 | ||
| High | 6.20 | 46.57 | 25.02 | ||
| Low | 5.93 | 44.19 | 23.52 | ||
| Last | 6.03 | 45.18 | 24.13 | ||
| Change | -0.06 | -0.02 | +0.12 | ||
| % Change | -0.99% | -0.04% | +0.50% | ||
| Volume | 19,936,699 | 1,282,800 | 4,248,500 | ||
| 20-Day Average Volume | 16,516,840 | 788,625 | 850,190 | ||
| Previous Close | 6.09 | 45.20 | 24.01 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.88 | 49.96 | 25.19 | ||
| 20-Day Raw Stochastic | 10.89% | 10.57% | 30.89% | ||
| 20-Day Relative Strength | 44.24% | 36.30% | 51.43% | ||
| Weighted Alpha | -50.46 | +9.50 | +4.34 | ||
| Today's Opinion | 48% Sell | 24% Sell | 64% Buy | ||
| Previous Opinion | 48% Sell | 24% Sell | 64% Buy | ||
| Last Month's Opinion | 88% Sell | 72% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.24% since 12/13/24 | -3.28% since 12/13/24 | +0.42% since 12/13/24 | ||
| Low | 5.93 on 12/20/24 | 43.32 on 12/19/24 | 22.74 on 12/19/24 | ||
| High | 7.85 on 12/16/24 | 48.77 on 12/16/24 | 25.54 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -0.17% since 11/20/24 | -17.60% since 11/20/24 | +1.73% since 11/20/24 | ||
| Low | 5.60 on 11/22/24 | 43.32 on 12/19/24 | 22.74 on 12/19/24 | ||
| High | 9.55 on 12/09/24 | 60.92 on 11/25/24 | 27.24 on 12/04/24 | ||
| 3-Month | |||||
| %Chg | -11.32% since 09/20/24 | -12.46% since 09/20/24 | +14.52% since 09/20/24 | ||
| Low | 5.60 on 11/22/24 | 43.32 on 12/19/24 | 19.07 on 10/09/24 | ||
| High | 9.55 on 12/09/24 | 60.92 on 11/25/24 | 27.24 on 12/04/24 | ||
| 6-Month | |||||
| %Chg | -34.10% since 06/20/24 | +10.76% since 06/20/24 | +24.57% since 06/20/24 | ||
| Low | 5.60 on 11/22/24 | 36.93 on 06/26/24 | 15.31 on 08/07/24 | ||
| High | 9.86 on 06/25/24 | 60.92 on 11/25/24 | 27.24 on 12/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,728,445 | 1,948,026 | 1,688,666 | ||
| Shares Outstanding, K | 286,641 | 43,117 | 69,982 | ||
| Annual Sales | 44,580,000 | 0 | 168,340,000 | ||
| Annual Net Income | -328,070,000 | -38,990,000 | -126,090,000 | ||
| Last Quarter Sales | 26,080,000 | 0 | 10,710,000 | ||
| Last Quarter Net Income | -95,840,000 | -76,620,000 | -45,140,000 | ||
| 60-Month Beta | 0.85 | -1.47 | 0.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 11/06/24 | -1.83 on 11/06/24 | -0.71 on 11/06/24 | ||
| Latest Earnings Date | 11/06/24 | 11/05/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||